Lung Transplantation: Clinical Trials

11 trials for Lung Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated, 1 unknown, 1 withdrawn. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 7, Terminated 2, Unknown 1, Withdrawn 1
Phase 22Completed 1, Unknown 1

Follow Lung Transplantation: new trials by email Literature Review of Lung Transplantation trials Research Report on Lung Transplantation

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postconditioning by Cyclosporin A in Pulmonary Transplantation
Cyclosporine A, Placebo - Lung Transplantation
Phase 3WithdrawnHospices Civils de Lyon2017-01-012019-03-14
Naloxone for Optimizing Hypoxemia Of Lung Donors
Naloxone, Normal saline - Brain Death, Organ Donors
Phase 2 / Phase 3CompletedWashington University School of Medicine1992015-09-012020-07-31
Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
standard therapy, Everolimus - Lung Transplantation
Phase 3CompletedNovartis Pharmaceuticals1302012-02-012019-03-14
A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients
mycophenolate mofetil - Lung Transplantation
Phase 3CompletedHoffmann-La Roche682010-01-012017-02-10
Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation
Advagraf®, Prograf® - Lung Transplantation
Phase 3TerminatedHannover Medical School252009-07-012018-08-22
Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation
Home spirometry with data transfer via cell phone, Home spirometer with BT-cellphone, Home spirometer w/o BT - Lung Transplantation
Phase 3CompletedHannover Medical School562007-07-012011-07-20
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study
Amphotericin B - Lung Transplantation, Fungal Infections
Phase 3CompletedUniversity of Pittsburgh482006-01-012008-12-17
Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients
Amphotericin B - Lung Transplantation, Lung Diseases
Phase 3TerminatedUniversity of Pittsburgh122005-10-012008-12-17
Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Everolimus, Mycophenolatmofetil - Lung Transplantation
Phase 3CompletedHannover Medical School1902005-03-012011-12-08
The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study
Surfactant (calfactant) - Lung Transplantation, Primary Graft Dysfunction
Phase 2 / Phase 3UnknownRabin Medical Center422005-01-012007-07-25
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
Amphotericin B - Lung Transplantation, Fungal Infections
Phase 3CompletedUniversity of Pittsburgh482004-09-012008-12-17

Narrower conditions

Mycoses (2)  ·  Brain Death (1)  ·  Bronchiolitis Obliterans (1)  ·  Lung Diseases (1)  ·  Opportunistic Infections (1)  ·  Primary Graft Dysfunction (1)

Broader conditions

Infections (3)  ·  Bacterial Infections and Mycoses (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Brain Diseases (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchitis (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Coma (1)  ·  Consciousness Disorders (1)  ·  Death (1)  ·  Lung Diseases (1)

Interventions

Amphotericin B (3)  ·  Everolimus (2)  ·  Mycophenolic Acid (2)  ·  Cyclosporine (1)  ·  Naloxone (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Standard of Care (1)  ·  Surface-Active Agents (1)  ·  Tacrolimus (1)  ·  calfactant (1)

Sponsors

Hannover Medical School (3)  ·  University of Pittsburgh (3)  ·  Hoffmann-La Roche (1)  ·  Hospices Civils de Lyon (1)  ·  Novartis Pharmaceuticals (1)  ·  Rabin Medical Center (1)  ·  Washington University School of Medicine (1)

Countries

Germany (5)  ·  United States (4)  ·  France (1)  ·  Israel (1)

Top investigators

Shahid Husain, MD (2)  ·  Jens Gottlieb, MD (1)  ·  Jens T Gottlieb, M.D. (1)  ·  Mark Ludwig (1)  ·  Martin Strueber, Dr. (1)  ·  MordechaI R Kramer, Prof (1)  ·  Rajat Dhar, MD (1)

Results publications

PMID 20881664, PMID 21265282, PMID 30399122, PMID 30615259, PMID 35283454

NIH funding

2009 (1)